Patents by Inventor Sabrina Casper

Sabrina Casper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12090257
    Abstract: A method for detecting occult hemorrhages is provided. The method includes obtaining a first hematocrit concentration prior to infusing a saline solution into a bloodstream of a patient. The method further includes infusing the saline solution into the bloodstream of the patient and obtaining a second hematocrit concentration after infusing the saline solution into the bloodstream. The method also includes determining a first absolute blood volume based on the first hematocrit concentration and the second hematocrit concentration. In addition, the method includes generating a notification indicating a potential occult hemorrhage based on the first absolute blood volume and a pre-defined absolute blood volume threshold, and providing the notification indicating the potential occult hemorrhage.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: September 17, 2024
    Assignees: Fresenius Medical Care Deutschland GmbH, Fresenius Medical Care Holdings, Inc.
    Inventors: Sabrina Casper, Peter Kotanko
  • Patent number: 12046375
    Abstract: A computing system for determining a systematic training strategy for the user is provided. The computing system includes a user device that uses one or more sensors to obtain partial pressure of oxygen (PO2) levels of a user over a period of time. The user device provides previous PO2 levels to a personalized erythropoiesis model generation computing platform. The computing platform obtains individualized user data for the user indicating or more previous hematocrit and/or hemoglobin measurements for the user. The computing platform determines an individualized erythropoiesis model for the user based on the one or more previous hematocrit and/or hemoglobin measurements and the previous PO2 information, and employs the individualized erythropoiesis model to determine predicted hematocrit and/or hemoglobin measurements. The computing platform performs one or more actions based on the one or more predicted hematocrit and/or hemoglobin measurements.
    Type: Grant
    Filed: October 5, 2022
    Date of Patent: July 23, 2024
    Assignees: Fresenius Medical Care Holdings, Inc., Fresenius Medical Care Deutschland GmbH
    Inventors: Peter Kotanko, Ulrike Kotanko, Sabrina Casper, David Joerg, Gudrun Schappacher-Tilp, Doris Fuertinger
  • Publication number: 20240127962
    Abstract: A computing system for determining a systematic training strategy for the user is provided. The computing system includes a user device that uses one or more sensors to obtain partial pressure of oxygen (PO2) levels of a user over a period of time. The user device provides previous PO2 levels to a personalized erythropoiesis model generation computing platform. The computing platform obtains individualized user data for the user indicating or more previous hematocrit and/or hemoglobin measurements for the user. The computing platform determines an individualized erythropoiesis model for the user based on the one or more previous hematocrit and/or hemoglobin measurements and the previous PO2 information, and employs the individualized erythropoiesis model to determine predicted hematocrit and/or hemoglobin measurements. The computing platform performs one or more actions based on the one or more predicted hematocrit and/or hemoglobin measurements.
    Type: Application
    Filed: October 5, 2022
    Publication date: April 18, 2024
    Inventors: Peter Kotanko, Ulrike Kotanko, Sabrina Casper, David Joerg, Gudrun Schappacher-Tilp, Doris Fuertinger